Determining the impact of body mass index on ultrasound accuracy for diagnosing appendicitis: Is it less useful in obese children?

Are Cases of Nonvisualized Appendix on Ultrasound Not Actually Appendicitis? Single-Center Results

BACKGROUND

Ultrasonography (USG), which is used as the first step in the diagnosis of acute appendicitis (AA), sometimes cannot visualize the appendix. The aim of this study was to retrospectively analyze the clinical, imaging, and pathology results of these cases and to provide information to clinicians about the next step to be taken.

METHODS

The study was performed retrospectively between January 1, 2021 and December 31, 2021. Patients with a prediagnosis of AA who underwent USG as the first-line imaging modality and in whom the appendix could not be visualized were included. Imaging, clinical, and pathology results of the patients were analyzed, and the study was completed by comparing patients with and without computed tomography (CT) scans as well as patients with and without AA diagnosis.

RESULTS

The study included 176 patients aged 18-89 years, 63 (35.8%) of whom were male and 113 (64.2%) female. The mean age was 37.5 ± 17.8 years. CT was not performed in 97 patients (55.1%), while it was performed in 79 patients (44.9%). Of the patients, 121 (68.7%) were discharged and 55 (31.2%) were hospitalized. Of the patients who were hospitalized, 36 (20.5%) received medical treatment and 19 (10.7%) received surgical treatment. Fifteen patients (8.5%) were pathologically diagnosed with AA. Two patients (1.1%) who were discharged without CT were subsequently diagnosed with AA. The white blood cell (WBC) count of patients operated on for AA was 13.4 ± 3.9 × 103/mL, while the WBC count of the other patients was 10.3 ± 4.2 × 103/mL (p = 0.009). The proportion of patients with an Alvarado score of ≥ 6 was 80% in patients diagnosed with AA, while this rate was 4.3% in other patients (p < 0.001).

CONCLUSIONS

In cases of a nonvisualized appendix on USG, the absence of leukocytosis and an Alvarado score below 6 may suggest a reduced likelihood of AA. Consequently, further investigations, such as CT and magnetic resonance imaging, could be avoided.

Novel Ultrasonographic Evaluation of Microvascular Blood Flow for Non-Operative Management of Uncomplicated Acute Appendicitis in Children: A Prospective Clinical Study

OBJECTIVES

To determine whether superb microvascular imaging (SMI) provides a more precise delineation between reversible and irreversible stages of uncomplicated acute appendicitis managed non-operatively.

METHODS

This prospective clinical study examined pediatric patients with acute appendicitis initially treated non-operatively and evaluated using power Doppler (PD) and SMI. We determined case severity, monitor appendiceal blood flow (BF), and appendicitis reversibility. Complicated cases were excluded. Severity was classified using B-mode as well as PD, or SMI: Grade I, smooth wall/normal BF; Grade IIa, irregular wall/increased BF; Grade IIb, irregular wall/decreased BF; and Grade III, absence of wall/loss of BF.

RESULTS

This study examined a total of 100 patients with acute appendicitis, after excluding 29 patients. All 10 patients with normal BF on PD (Grade I) showed similar BF on SMI (Grade I). Among 29 patients with increased BF on PD (Grade IIa), corresponding increased BF was noted on SMI (Grade IIa), and all these patients showed full recovery. Of the 55 patients showing decreased BF on PD (Grade IIb), 52 showed increased BF on SMI (Grade IIa). The remaining three patients, identified with an impacted appendicolith, showed decreased BF on SMI (Grade IIb) and experienced treatment failure, subsequently developing abscesses. In all six patients with undetectable BF on PD (Grade III), SMI similarly could not detect appendiceal BF (Grade III), and non-operative management failed for these patients.

CONCLUSIONS

SMI offers an objective and effective means of delineating the threshold between reversible and irreversible stages in uncomplicated acute appendicitis following non-operative management.

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Diagnostic Imaging of Suspected Acute Appendicitis in Adults, Children, and Pregnant People

This paper is part of a clinical practice guideline update on the risk assessment, diagnostic imaging, and microbiological evaluation of complicated intra-abdominal infections in adults, children, and pregnant people, developed by the Infectious Diseases Society of America (IDSA). In this paper, the panel provides recommendations for diagnostic imaging of suspected acute appendicitis. The panel's recommendations are based on evidence derived from systematic literature reviews and adhere to a standardized methodology for rating the certainty of evidence and strength of recommendation according to the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach.

A randomized, controlled multicenter feasibility pilot trial on imaging confirmed uncomplicated acute appendicitis: Appendectomy vs. symptomatic treatment in pediatric patients (the APPSYPP) trial study protocol

INTRODUCTION

Imaging-confirmed uncomplicated acute appendicitis can be effectively and safely treated with antibiotics in most adults and children. Symptomatic treatment may have similar efficacy and safety.

METHODS AND ANALYSIS

The APPSYPP trial is a randomized national multicenter feasibility superiority pilot study comparing appendectomy with symptomatic treatment in children with imaging-confirmed uncomplicated acute appendicitis.

INCLUSION CRITERIA

1) age ≥ 7 and < 16 years, 2) imaging-confirmed uncomplicated acute appendicitis and 3) CRP ≤ 65 mg/l. Patients are randomized to receive emergency laparoscopic appendectomy or symptomatic treatment. To ensure patient safety, symptomatically treated patients are hospitalized for at least 24 h receiving standard practice intravenous fluids and analgesics according to standard clinical practice. Primary outcome is 30-day treatment success defined by the absence of any treatment failure criteria. In appendectomy, treatment failure is defined as normal appendiceal histopathology or any postintervention complication requiring general anesthesia. In symptomatic treatment, treatment failure is defined as 1) inability for hospital discharge without appendectomy within 48 h after randomization with a finding of histopathologically inflamed appendix, 2) appendectomy during the initial hospital stay due to clinical progression of appendicitis with complicated acute appendicitis both histopathologically and surgically, 3) appendectomy with a histopathological finding of acute appendicitis after hospital discharge, or 4) any complication of appendicitis requiring general anesthesia. Detailed predefined secondary outcomes will be analyzed.

ETHICS AND DISSEMINATION

Study was approved by Ethics Committee of Helsinki University Hospital (ID:HUS/1993/2021), conducted in compliance with the declaration of Helsinki with results disseminated in peer-reviewed scientific journals.

TRIAL REGISTRATION

ClinicalTrials.gov (NCT05289713).

STRENGTHS AND LIMITATIONS OF THIS STUDY